canrenoic acid has been researched along with ST Elevated Myocardial Infarction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beygui, F; Ecollan, P; Flather, M; Hamm, CW; Lopez De Sa, E; Machecourt, J; Montalescot, G; Pitt, B; Van Belle, E; Verheugt, FWA; Vicaut, E; Zannad, F | 1 |
| Blackman, D; Bulluck, H; Davies, J; Fröhlich, GM; Gamma, R; Garg, P; Greenwood, JP; Hausenloy, DJ; Mathur, A; Mohdnazri, S; Moon, JC; Nicholas, JM; Sirker, A | 1 |
1 review(s) available for canrenoic acid and ST Elevated Myocardial Infarction
| Article | Year |
|---|---|
Individual participant data analysis of two trials on aldosterone blockade in myocardial infarction.
Topics: Aged; Canrenoic Acid; Eplerenone; Equivalence Trials as Topic; Female; Humans; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Multicenter Studies as Topic; Risk Factors; Spironolactone; ST Elevation Myocardial Infarction; Time Factors; Treatment Outcome | 2018 |
1 trial(s) available for canrenoic acid and ST Elevated Myocardial Infarction
| Article | Year |
|---|---|
Mineralocorticoid receptor antagonist pre-treatment and early post-treatment to minimize reperfusion injury after ST-elevation myocardial infarction: The MINIMIZE STEMI trial.
Topics: Aged; Canrenoic Acid; Cardiac Imaging Techniques; Double-Blind Method; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Myocardial Reperfusion Injury; Percutaneous Coronary Intervention; Pilot Projects; Proof of Concept Study; Spironolactone; ST Elevation Myocardial Infarction; Ventricular Remodeling | 2019 |